Acute leukemia, Myelodysplastic syndrome, Malignant lymphoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who have hematologic malignancies as defined at least one of the following: a) Acute Leukemia b) MDS/MPD c) Lymphoma, CR or chemosensitive PR 2.Age: over 20 years old. 3.Patients who have cord blood with following criteria a) Disclosed in Cord Blood Banks in Japan b) HLA, more than 4/6 matched c) NCC, more than 2.0X107/kg d) no DSA. 4.Patients who give written informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who are not eligible for this study at the discretion of the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of grade III-IV acute GVHD at 100 days | — |
Countries
Japan
Contacts
Hokkaido university hospital Department of hematology